Chao-chih Wu

Title: Innovations of Chao-chih Wu in Immunotherapy

Introduction

Chao-chih Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on antibodies targeting immunogenic glycopeptides. With a total of two patents to his name, Wu's research is paving the way for advancements in cancer treatment.

Latest Patents

Wu's latest patents include groundbreaking work on antibodies against immunogenic glycopeptides. These antibodies specifically bind to at least one epitope defined by the immunogenic glycopeptide. The patents also disclose pharmaceutical compositions comprising these antibodies and methods for preventing and/or treating Globo-H-positive cancer. This innovative approach holds promise for improving therapeutic options for patients suffering from this type of cancer.

Career Highlights

Chao-chih Wu is affiliated with the Mackay Medical Foundation, which is part of the Presbyterian Church in Taiwan and Mackay Memorial Hospital. His work at this esteemed institution allows him to collaborate with other leading researchers and contribute to significant advancements in medical science.

Collaborations

Some of Wu's notable coworkers include Chih-Long Chang and Chih-long Chang. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.

Conclusion

Chao-chih Wu's contributions to immunotherapy through his patents and research are noteworthy. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in cancer treatment.